Dan Benjamin Teleman
Chief Executive Officer, Director · Nasus Pharma Ltd
IndividualBuying only
- 2026
- Jul 29, 2026
- 4
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Dan Benjamin Teleman's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- RA CAPITAL MANAGEMENT, L.P. - $199.99M in TYRA purchases and sales in the last 12 months
- John Oyler - $189.61M in ONC purchases and sales in the last 12 months
- BVF PARTNERS L P - $173.67M in KYMR purchases and sales in the last 12 months
- BAKER BROS. ADVISORS LP - $172.50M in KYMR purchases and sales in the last 12 months
- Keith S. Manchester - $154.47M in ROIV purchases and sales in the last 12 months
- QVT Financial LP - $147.38M in ROIV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Dan Benjamin Teleman?
Dan Benjamin Teleman is a corporate insider, tracked as Chief Executive Officer, Director of Nasus Pharma Ltd (NSRX). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Dan Benjamin Teleman last file a Form 4?
The most recent primary Form 4 on record is dated 29 July 2026, one of 4 filings going back to 2026.
Has Dan Benjamin Teleman been buying or selling stock?
Recorded transactions: 3 open-market purchases ($62K) and 0 open-market sales across all tracked filings.
